Dana-Farber News shared on X:
“Congratulations to Dana-Farber’s Judy Garber, recipient of the prestigious 2026 Basser Global Prize in recognition of her pioneering and transformative contributions to the treatment and understanding of BRCA related cancers.”
Judy E. Garber is the Susan F. Smith Chair and Chief of the Division of Cancer Genetics and Prevention at Dana-Farber Cancer Institute and a Professor of Medicine at Harvard Medical School.
She conducts research in clinical cancer genetics, with a special focus in genetics of breast cancer. Dr. Garber is also a leader in research into the characteristics and treatment of triple negative breast cancer, the most common form in women with BRCA1 mutations and an expert in Li-Fraumeni Syndrome.
Her translational research focuses on the evaluation of novel agents targeting DNA repair defects in breast cancer, including PARP inhibitors for treatment and prevention of breast cancer and other BRCA-associated cancers, and the study of other agents for reduction of breast cancer risk.[1]
You can also read:
Asaf Maoz: Congratulating Judy Garber on Receiving the LFSA Global Pioneer Award
